If industry has difficulty getting to data it needs, so does FDA. Only the Agency doesn't have all of that data, as became evident during the Vioxx disaster. Databases run by private insurers provide a wealth of drug safety information, waiting to be tapped, the former FDA Commissioner suggested at an Institute of Medicine meeting yesterday. Click here for more on that.
